X
Bayer boosts cell therapy pipeline with BlueRock acquisition
https://pharmaphorum.com/news/bayer-boosts-cell-therapy-pipeline-with-bluerock-acquisition/
Parkinson’s disease
e-Therapeutics and C4XD research Parkinson’s drugs
Biotechs search for new treatments for incurable disease
FDA probes Parkinson’s drug safety, Acadia’s shares collapse
FDA under pressure to act following press reports
Acadia shares hit by media doubts over Parkinson’s drug
CNN report raises safety concerns
1 2